Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier organic anion transporter family member 1A2 is a sodium-independent membrane transporter encoded by the SLCO1A2 gene in humans. It mediates cellular uptake of a variety of endogenous and exogenous organic ions—including bile acids, steroid conjugates such as dehydroepiandrosterone sulfate (DHEAS), bromosulphophthalein, and certain drugs—in tissues such as liver, brain, lung, and intestine. The protein belongs to the SLC21 family (now often referred to as SLCO) and plays a key role in xenobiotic metabolism and pharmacokinetics. Genetic variation in SLCO1A2 has been associated with differences in drug response; it has also been identified as a susceptibility locus for some neurodegenerative diseases.
Drugs targeting or utilizing this transporter typically act by modulating or relying on its function for cellular uptake and distribution—especially hepatic and intestinal transport—of their active forms or metabolites.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier organic anion transporter family member 1A2 (OATP1A2).